These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22339151)

  • 41. Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes.
    Inazu M; Takeda H; Maehara K; Miyashita K; Tomoda A; Matsumiya T
    J Neurochem; 2006 Apr; 97(2):424-34. PubMed ID: 16539668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. L-tetrahydropalmatine reduces oxaliplatin accumulation in the dorsal root ganglion and mitochondria through selectively inhibiting the transporter-mediated uptake thereby attenuates peripheral neurotoxicity.
    Yi Y; Li L; Song F; Li P; Chen M; Ni S; Zhang H; Zhou H; Zeng S; Jiang H
    Toxicology; 2021 Jul; 459():152853. PubMed ID: 34252480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The inhibitory effect of antiretroviral drugs on the L-carnitine uptake in human placenta.
    Karahoda R; Ceckova M; Staud F
    Toxicol Appl Pharmacol; 2019 Apr; 368():18-25. PubMed ID: 30735677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholesterol stimulates the cellular uptake of L-carnitine by the carnitine/organic cation transporter novel 2 (OCTN2).
    Zhang L; Gui T; Console L; Scalise M; Indiveri C; Hausler S; Kullak-Ublick GA; Gai Z; Visentin M
    J Biol Chem; 2021; 296():100204. PubMed ID: 33334877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5).
    Tahara H; Yee SW; Urban TJ; Hesselson S; Castro RA; Kawamoto M; Stryke D; Johns SJ; Ferrin TE; Kwok PY; Giacomini KM
    J Pharmacol Exp Ther; 2009 Apr; 329(1):262-71. PubMed ID: 19141711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cisplatin-induced downregulation of OCTN2 affects carnitine wasting.
    Lancaster CS; Hu C; Franke RM; Filipski KK; Orwick SJ; Chen Z; Zuo Z; Loos WJ; Sparreboom A
    Clin Cancer Res; 2010 Oct; 16(19):4789-99. PubMed ID: 20858838
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutation in an adaptor protein PDZK1 affects transport activity of organic cation transporter OCTNs and oligopeptide transporter PEPT2.
    Sugiura T; Kato Y; Kubo Y; Tsuji A
    Drug Metab Pharmacokinet; 2006 Oct; 21(5):375-83. PubMed ID: 17072090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Involvement of OCTN2 in the transport of acetyl-L-carnitine across the inner blood-retinal barrier.
    Tachikawa M; Takeda Y; Tomi M; Hosoya K
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):430-6. PubMed ID: 19684012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tight junction protein ZO-1 controls organic cation/carnitine transporter OCTN2 (SLC22A5) in a protein kinase C-dependent way.
    Jurkiewicz D; Michalec K; Skowronek K; Nałęcz KA
    Biochim Biophys Acta Mol Cell Res; 2017 May; 1864(5):797-805. PubMed ID: 28257821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and in vitro characterization of drug conjugates of l-carnitine as potential prodrugs that target human Octn2.
    Diao L; Polli JE
    J Pharm Sci; 2011 Sep; 100(9):3802-16. PubMed ID: 21455979
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carnitine/organic cation transporter OCTN2 (Slc22a5) is responsible for renal secretion of cephaloridine in mice.
    Kano T; Kato Y; Ito K; Ogihara T; Kubo Y; Tsuji A
    Drug Metab Dispos; 2009 May; 37(5):1009-16. PubMed ID: 19220985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency.
    Tang NL; Ganapathy V; Wu X; Hui J; Seth P; Yuen PM; Wanders RJ; Fok TF; Hjelm NM
    Hum Mol Genet; 1999 Apr; 8(4):655-60. PubMed ID: 10072434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of OCTN2 and OCTN3 in the apical membrane of rat renal cortex and medulla.
    Cano MM; Calonge ML; Ilundain AA
    J Cell Physiol; 2010 May; 223(2):451-9. PubMed ID: 20112288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective inhibition of OCTN2 is more effective than inhibition of gamma-butyrobetaine dioxygenase to decrease the availability of l-carnitine and to reduce myocardial infarct size.
    Liepinsh E; Makrecka M; Kuka J; Cirule H; Makarova E; Sevostjanovs E; Grinberga S; Vilskersts R; Lola D; Loza E; Stonans I; Pugovics O; Dambrova M
    Pharmacol Res; 2014 Jul; 85():33-8. PubMed ID: 24836867
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carnitine and γ-Butyrobetaine Stimulate Elimination of Meldonium due to Competition for OCTN2-mediated Transport.
    Liepinsh E; Makarova E; Sevostjanovs E; Hartmane D; Cirule H; Zharkova-Malkova O; Grinberga S; Dambrova M
    Basic Clin Pharmacol Toxicol; 2017 May; 120(5):450-456. PubMed ID: 27983775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition.
    Enomoto A; Wempe MF; Tsuchida H; Shin HJ; Cha SH; Anzai N; Goto A; Sakamoto A; Niwa T; Kanai Y; Anders MW; Endou H
    J Biol Chem; 2002 Sep; 277(39):36262-71. PubMed ID: 12089149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).
    Urban TJ; Gallagher RC; Brown C; Castro RA; Lagpacan LL; Brett CM; Taylor TR; Carlson EJ; Ferrin TE; Burchard EG; Packman S; Giacomini KM
    Mol Pharmacol; 2006 Nov; 70(5):1602-11. PubMed ID: 16931768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Advances in the study of regulation of novel organic cation transporter-2].
    Wang FR; Guo RC
    Yao Xue Xue Bao; 2009 Oct; 44(10):1061-5. PubMed ID: 20055125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional activity of L-carnitine transporters in human airway epithelial cells.
    Ingoglia F; Visigalli R; Rotoli BM; Barilli A; Riccardi B; Puccini P; Dall'Asta V
    Biochim Biophys Acta; 2016 Feb; 1858(2):210-9. PubMed ID: 26607009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression and localization of carnitine/organic cation transporter OCTN1 and OCTN2 in ocular epithelium.
    Garrett Q; Xu S; Simmons PA; Vehige J; Flanagan JL; Willcox MD
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4844-9. PubMed ID: 18641280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.